INSIGHT: International Nifedipine GITS Study Intervention as a Goal in Hypertension Treatment

Journal of Human Hypertension

Volumn 10, Issue SUPPL. 3, 1996, Pages

  Brown, M J ^a,h   Castaigne, A ^b   Ruilope, L M ^c   Mancia, G ^d   Rosenthal, T ^e   De Leeuw, P W ^f   Ebner, F ^g  

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^b Fed des Services de Cardiologie   (France)

^c HOSPITAL UNIVERSITARIO 12 DE OCTUBRE   (Spain)

^d UNIVERSITY OF MILAN   (Italy)

^e SHEBA MEDICAL CENTER   (Israel)

^f MAASTRICHT UNIVERSITY   (Netherlands)

^g BAYER AG   (Germany)

^h ADDENBROOKE S HOSPITAL   (United Kingdom)

Author keywords

Morbidity; Mortality; Nifedipine; Outcome trial; Thiazide

Indexed keywords

AMILORIDE PLUS HYDROCHLOROTHIAZIDE; ATENOLOL; CALCIUM CHANNEL BLOCKING AGENT; ENALAPRIL; NIFEDIPINE; THIAZIDE DIURETIC AGENT;

ADULT; AGED; CLINICAL TRIAL; CONFERENCE PAPER; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DENMARK; DOSE CALCULATION; FOLLOW UP; FRANCE; HEART FAILURE; HEART INFARCTION; HUMAN; HYPERTENSION; ISRAEL; ITALY; MAJOR CLINICAL STUDY; MULTICENTER STUDY; NETHERLANDS; NORWAY; RANDOMIZED CONTROLLED TRIAL; RISK FACTOR; SPAIN; STROKE; SUBARACHNOID HEMORRHAGE; SUDDEN DEATH; SWEDEN; SYSTOLIC BLOOD PRESSURE; UNITED KINGDOM;

AGED; AGED, 80 AND OVER; AMILORIDE; CALCIUM CHANNEL BLOCKERS; DELAYED-ACTION PREPARATIONS; DIURETICS; DOUBLE-BLIND METHOD; DRUG COMBINATIONS; HUMANS; HYDROCHLOROTHIAZIDE; HYPERTENSION; INTERNATIONAL COOPERATION; MIDDLE AGED; NIFEDIPINE; RISK FACTORS; SODIUM CHLORIDE SYMPORTER INHIBITORS;

EID: 0029745614     PISSN: 09509240     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (6)

1. Yusuf S, Lessem J, Prabhat J, Lonn E. Primary and secondary prevention of myocardial infarction and strokes: an update of randomly allocated, controlled trials. J Hypertension 1993; 11 (Suppl 4): 561-573.
2. The Fifth Report of the Joint National Committee on Detection, Evaluation and Treatment of High Blood Pressure (JNC V). Arch Intern Med 1993; 153: 154-183.
3. Sever P et al. Management guidelines in essential hypertension: report of the second working party of the British Hypertension Society. Br Med J 1993; 306: 983-987.
4. Guidelines Sub-Committee of the WHO/ISH Mild Hypertension Liaison Committee. 1993 Guidelines for the Management of Mild Hypertension: Memorandum from a WHO/ISH Meeting. J Hypertens 1993; 11: 905-918.
5. Wilhelmsen L, Wedel H, Tibblin G. Multivariate analysis of risk factors for coronary heart disease. Circulation 1983; 48: 950-958.
6. Vaughan Reed J, Wickham EA. Practical experience of minimisation in clinical trials, Pharmaceut Med 1988; 3: 349-359.